Hjem › Melanom
Melanom kliniske forsøg rekrutterer i USA
197 studier for Melanom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- St. Louis, MO21 studier
- Columbus, OH21 studier
- Salt Lake City, UT21 studier
- Arlington, VA20 studier
- Dallas, TX20 studier
- Tampa, FL19 studier
- Denver, CO19 studier
- San Diego, CA18 studier
- Aurora, CO18 studier
- Washington, DC17 studier
- Seattle, WA17 studier
- Cincinnati, OH17 studier
- Grand Rapids, MI17 studier
- Rochester, MN16 studier
- Queens, NY16 studier
- Jacksonville, FL16 studier
- San Antonio, TX15 studier
- Madison, WI15 studier
- Edison, NJ15 studier
- Portland, OR15 studier
- Orlando, FL15 studier
- Chicago, IL15 studier
- Orange, CA14 studier
- Cleveland, OH13 studier
- Ann Arbor, MI12 studier
- Minneapolis, MN12 studier
- Omaha, NE12 studier
- Austin, TX11 studier
- Baltimore, MD11 studier
- Richmond, VA11 studier
Efter delstat
- Alabama12 studier
- Alaska5 studier
- Arizona26 studier
- Arkansas13 studier
- Californien70 studier
- Colorado32 studier
- Connecticut13 studier
- Delaware6 studier
- District of Columbia7 studier
- Florida55 studier
- Georgia23 studier
- Hawaii3 studier
- Idaho8 studier
- Illinois22 studier
- Indiana14 studier
- Iowa12 studier
- Kansas15 studier
- Kentucky21 studier
- Louisiana9 studier
- Maine4 studier
- Maryland24 studier
- Massachusetts29 studier
- Michigan31 studier
- Minnesota29 studier
- Mississippi3 studier
- Missouri23 studier
- Montana8 studier
- Nebraska16 studier
- Nevada6 studier
- New Hampshire6 studier
- New Jersey24 studier
- New Mexico11 studier
- New York50 studier
- North Carolina31 studier
- North Dakota9 studier
- Ohio40 studier
- Oklahoma14 studier
- Oregon15 studier
- Pennsylvania47 studier
- Rhode Island5 studier
- South Carolina10 studier
- South Dakota7 studier
- Tennessee40 studier
- Texas77 studier
- Utah26 studier
- Vermont5 studier
- Virginia34 studier
- Washington25 studier
- West Virginia7 studier
- Wisconsin20 studier
- Wyoming3 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
4 Weeks – 99 Years · Alle køn · Opdateret 2. okt. 2026 · NCT00040352Evaluation for NCI Surgery Branch Clinical Research Protocols
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT00001823Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
RekruttererFase 2
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT05155033Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07751042A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06365619NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07740941The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07281924A Study of BI 3810944 in Patients With Advanced Cancer
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07224425Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07519655A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06961006DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06246916Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06548789Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT05727904A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RekruttererFase 2
Op til 25 år · Alle køn · Opdateret 24. sep. 2026 · NCT07621614Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379Pan-tumor MRD Study
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RekruttererFase 3
Alder 75 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07068074Intratumoral N17350 in Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07339176Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.